头颈癌微血管重建术后抗生素预防谱与手术感染的多中心评估
该多中心横断面嵌套病例对照研究纳入2003年至2016年9家美国三级中心的1307例头颈癌微血管重建患者,评估30天手术部位感染(SSI)的患病率及危险因素。结果显示30天SSI发生率为15%,无革兰阴性菌覆盖的术后抗生素预防与SSI独立相关(aOR 2.2),而抗假单胞菌覆盖或延长预防(≥6天)无保护作用。
要点
- 无革兰阴性菌覆盖的术后抗生素预防与30天SSI风险增高独立相关,应避免使用。
- 抗假单胞菌覆盖或预防疗程≥6天并未降低SSI风险,不支持常规延长或拓宽谱。
- 女性及手术时长≥11.8小时也是30天SSI的独立危险因素。
核心结论
- 无革兰阴性菌覆盖的术后抗生素预防与30天SSI显著相关,应避免使用。
- 抗假单胞菌覆盖或延长预防疗程(≥6天)对SSI无保护作用。
- 应开展抗菌药物管理干预以减少不必要抗生素暴露、防止耐药并改善预后。
研究设计与样本
- 横断面研究嵌套病例对照设计,纳入9家美国三级中心2003年1月至2016年3月收治的头颈癌微血管重建住院患者。
- 共纳入1307例患者,其中1003例(77%)有术后抗生素预防数据。
- 病例为30天内发生SSI的患者,对照为30天时无SSI的患者。
主要发现
- 30天SSI发生于189例(15%)患者,中位发生时间为11.5天(四分位距7-17天)。
- 59%的SSI分离出病原体,耐甲氧西林金黄色葡萄球菌(6%)和铜绿假单胞菌(9%)不常见。
- 术后抗生素预防方案分布:无革兰阴性菌覆盖17%,肠杆菌科革兰阴性菌覆盖52%,抗假单胞菌革兰阴性菌覆盖31%。
- 与30天SSI独立相关的变量包括女性(aOR 1.6;95%CI 1.1-2.2)、无革兰阴性菌覆盖的预防(aOR 2.2;95%CI 1.5-3.3)和手术时长≥11.8小时(aOR 1.9;95%CI 1.3-2.7)。
- 较长的预防疗程(≥6天)或抗假单胞菌预防与SSI无关联。
关键数值与推荐
- 30天SSI患病率为15%(189/1307)。
- 无革兰阴性菌覆盖的术后抗生素预防与SSI的aOR为2.2(95%CI 1.5-3.3)。
- 手术时长≥11.8小时的aOR为1.9(95%CI 1.3-2.7),女性的aOR为1.6(95%CI 1.1-2.2)。
- 抗假单胞菌预防或预防疗程≥6天与SSI无显著关联。
临床怎么用
- 头颈癌微血管重建术后应避免使用无革兰阴性菌覆盖的抗生素预防方案。
- 不应常规延长预防疗程至≥6天或使用抗假单胞菌覆盖来预防SSI。
- 应结合女性、手术时长≥11.8小时等危险因素识别高风险患者并加强监测。
局限性
- 横断面嵌套病例对照设计可能限制因果推断。
- 仅77%患者有术后抗生素预防数据,可能存在选择偏倚。
- 未报告各中心具体预防方案细节及SSI定义标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective To characterize and identify risk factors for 30-day surgical site infections (SSIs) in patients with head and neck cancer who underwent microvascular reconstruction. Study Design Cross-sectional study with nested case-control design. Setting Nine American tertiary care centers. Subjects and Methods Hospitalized patients were included if they underwent head and neck cancer microvascular reconstruction from January 2003 to March 2016. Cases were defined as patients who developed 30-day SSI; controls were patients without SSI at 30 days. Postoperative antibiotic prophylaxis (POABP) regimens were categorized by Gram-negative (GN) spectrum: no GN coverage, enteric GN coverage, and enteric with antipseudomonal GN coverage. All POABP regimens retained activity against anaerobes and Gram-positive bacteria. Thirty-day prevalence of and risk factors for SSI were evaluated. Results A total of 1307 patients were included. Thirty-day SSI occurred in 189 (15%) patients; median time to SSI was 11.5 days (interquartile range, 7-17). Organisms were isolated in 59% of SSI; methicillin-resistant Staphylococcus aureus (6%) and Pseudomonas aeruginosa (9%) were uncommon. A total of 1003 (77%) patients had POABP data: no GN (17%), enteric GN (52%), and antipseudomonal GN (31%). Variables independently associated with 30-day SSI were as follows: female sex (adjusted odds ratio [aOR], 1.6; 95% CI, 1.1-2.2), no GN POABP (aOR, 2.2; 95% CI, 1.5-3.3), and surgical duration ≥11.8 hours (aOR, 1.9; 95% CI, 1.3-2.7). Longer POABP durations (≥6 days) or antipseudomonal POABP had no association with SSI. Conclusions POABP without GN coverage was significantly associated with SSI and should be avoided. Antipseudomonal POABP or longer prophylaxis durations (≥6 days) were not protective against SSI. Antimicrobial stewardship interventions should be made to limit unnecessary antibiotic exposures, prevent the emergence of resistant organisms, and improve patient outcomes.
引用
- Veve MP, Greene JB, Williams AM, et al. Multicenter Assessment of Antibiotic Prophylaxis Spectrum on Surgical Infections in Head and Neck Cancer Microvascular Reconstruction. Otolaryngol Head Neck Surg. 2018. PMID: 29513083. doi:10.1177/0194599818756299
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。